Latest Period
n/a
Security Snapshot
Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share (APVO) Institutional Ownership
CUSIP: 03835L504
13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.61
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- APVO on Nasdaq
- Shares outstanding
- 3,295,607
- SEC-reported price per share
- $0.61
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- APVO - Aptevo Therapeutics Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 03835L504.
- Latest finished 13F holder period is not available.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 12 to 0 between Q3 2025 and Q4 2025.
- SEC-reported value moved from $717,121 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
03835L504
Latest holder period
n/a
13F holders
13D/G owners
4
CIK / CUSIP context first
APVO full holder history
Aptevo Therapeutics Inc. SEC filings
Aptevo Therapeutics Inc. company facts
Aptevo Therapeutics Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03835L504:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
APVO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| YA II PN, Ltd. | 10% | $1,663,965 | 357,842 | YA II PN, Ltd. | 16 Jun 2025 | |||
| CVI Investments, Inc. | 9.9% | $1,073,526 | 357,842 | CVI Investments, Inc. | 30 Jun 2025 | |||
| L1 Capital Global Opportunities Master Fund, Ltd. | 5% | -50% | $492,900 | -$362,100 | 164,300 | -42% | L1 Capital Global Opportunities Master Fund, Ltd. | 14 Aug 2025 |
| BANK OF AMERICA CORP /DE/ | 0% | -100% | $125 | -$715,879 | 86 | -100% | BANK OF AMERICA CORP /DE/ | 31 Oct 2025 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
n/a
Rows shown
1-3 of 3